J Cancer 2011; 2:360-362. doi:10.7150/jca.2.360

Short Report

Adoptive Cell Therapy for Patients with Melanoma

Mark E. Dudley

Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892-1201, USA

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Citation:
Dudley ME. Adoptive Cell Therapy for Patients with Melanoma. J Cancer 2011; 2:360-362. doi:10.7150/jca.2.360. Available from http://www.jcancer.org/v02p0360.htm

File import instruction

Abstract

Adoptive cell therapy can be an effective treatment for some patients with advanced cancer. This report summarizes clinical trial results from the Surgery Branch, NCI, investigating tumor infiltrating lymphocytes (TIL) and gene engineered peripheral blood T cells for the therapy of patients with melanoma and other solid tumors.

Keywords: TIL, melanoma, NY-ESO-1, interleukin-2, lymphodepletion